Case report: lactic acidosis and rhabdomyolysis during telbivudine and tenofovir treatment for chronic hepatitis B

BACKGROUND: Current treatment options for chronic hepatitis B (CHB) are pegylated interferon alpha and nucleoside analogues (NAs). NAs have relatively fewer side effects than interferon alpha, and generally well tolerated. Previously 12.9% of patients on telbivudine treatment were reported to develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ying, Yue, Hu, Yue-Kai, Jin, Jia-Lin, Zhang, Ji-Ming, Zhang, Wen-Hong, Huang, Yu-Xian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889588/
https://www.ncbi.nlm.nih.gov/pubmed/29625557
http://dx.doi.org/10.1186/s12876-018-0773-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889588/
https://www.ncbi.nlm.nih.gov/pubmed/29625557
http://dx.doi.org/10.1186/s12876-018-0773-3

Ejemplares similares